Comparative Efficacy and Safety of Tezepelumab and Dupilumab in Patients with Inadequately Controlled Asthma According to Thresholds of Type 2 Inflammatory Biomarkers: A Systematic Review and Network Meta-Analysis
Not Applicable
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000044672
- Lead Sponsor
- Showa University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5524
Inclusion Criteria
Not provided
Exclusion Criteria
Patients under 12 years old Non-RCTs, phase 1, 2 or, non-phase 3 RCTs, case-control studies, and cohort studies.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method